Tamara A Favorito's Net Worth

$219 Thousand

Estimate Recalculated Nov 1, 2024 10:17AM EST

Who is Tamara A Favorito

Tamara A Favorito does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SIGNAL GENETICS, INC., ARTELO BIOSCIENCES, INC., ZEVRA THERAPEUTICS, INC., Kintara Therapeutics, Inc., and FAVRILLE INC.

SEC CIK

Tamara A Favorito's CIK is 0001288232

Past Insider Trading and Trends

2024 was Tamara A Favorito's most active year for acquiring shares with 6 total transactions. Tamara A Favorito's most active month to acquire stocks was the month of February. 2024 was Tamara A Favorito's most active year for disposing of shares, totalling 5 transactions. Tamara A Favorito's most active month to dispose stocks was the month of January. 2023 saw Tamara A Favorito paying a total of $2,502.36 for 58,219 shares, this is the most they've acquired in one year. In 2015 Tamara A Favorito cashed out on 31,522 shares for a total of $13,294.32, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SIGNAL GENETICS, INC.

CFO, Secretary, Treasurer
Updated Nov 02, 2016
Form 4
-38.47%
-66.55K
$0.36
-$23.96K
Nov 02, 2016
106.45K
Options
Oct 31
Form 4
-12.56%
-10.48K
$0.49
-$5.08K
Aug 10, 2016
72.99K
Options
Aug 08
Form 4
100.00K
May 19, 2016
100.00K
Grant
Mar 28
Form 4
60.00K
Aug 14, 2015
60.00K
Grant
Aug 12
Form 4
-9.26%
-8.52K
$1.56
-$13.29K
Aug 05, 2015
83.48K
Options
Aug 04
Form 4
92.00K
Aug 04, 2014
92.00K
Grant
Aug 04
Form 3
Aug 04, 2014
Showing 7 results

ARTELO BIOSCIENCES, INC.

Investor
Updated Mar 01, 2024
Form 4
Mar 01, 2024
5.08K
Acq/Dis
Feb 28
Form 4
1.08K
Aug 08, 2023
1.08K
Grant
Form 4
667.00
Jul 03, 2023
667.00
Grant
Form 4
10.00K
Jun 27, 2022
10.00K
Grant
Form 4
10.00K
Jul 26, 2021
10.00K
Grant
Form 4
30.00K
Mar 09, 2021
30.00K
Grant
Form 3
Mar 09, 2021
Showing 7 results

ZEVRA THERAPEUTICS, INC.

Investor
Updated May 15, 2024
Form 4
49.20K
May 15, 2024
49.20K
Grant
May 13
Form 4
10.00K
Jun 02, 2023
10.00K
Grant
May 31
Form 4
39.20K
May 08, 2023
39.20K
Grant
Apr 25
Form 4
259.50%
519.00
$4.82
$2.50K
Mar 21, 2023
719.00
Purchase
Mar 17
Form 4
15.00K
Jun 30, 2022
15.00K
Grant
Jun 28
Form 4
200.00
$4.87
$974.00
May 24, 2022
200.00
Purchase
May 20
Form 3
Aug 18, 2021
Showing 7 results

Kintara Therapeutics, Inc.

Investor
Updated Sep 01, 2023
Form 4
8.50K
Sep 01, 2023
8.50K
Grant
Aug 30
Form 4
100.00K
Jul 05, 2022
100.00K
Grant
Jul 01
Form 4
35.00K
Sep 22, 2021
35.00K
Grant
Sep 22
Form 4
75.00K
May 03, 2021
75.00K
Grant
Apr 29
Form 3
May 03, 2021
Showing 5 results

FAVRILLE INC

Chief Financial Officer
Updated Jan 29, 2009
Form 4
855.51K
Jan 29, 2009
855.51K
Grant
Jan 27
Form 4
-10.96%
-5.00K
$0.02
-$91.50
Dec 18, 2008
40.64K
Sale
Dec 17
Form 4
-2.14%
-1.00K
Apr 28, 2008
45.64K
Grant
Apr 28
Form 4
-3.02%
-1.45K
Jan 23, 2008
46.64K
Grant
Jan 22
Form 4
61.98K
Mar 05, 2007
61.98K
Grant
Mar 02
Form 4
$0.63
$9.45K
Sep 28, 2006
134.12K
Options
Feb 07 - Sep 27
Form 4
50.02K
Mar 27, 2006
50.02K
Grant
Mar 23
Form 4
31.78K
Apr 12, 2005
31.78K
Grant
Mar 29
Form 3
Feb 02, 2005
33.09K
Showing 9 results